Viewing Study NCT02821559


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-07 @ 8:38 AM
Study NCT ID: NCT02821559
Status: COMPLETED
Last Update Posted: 2016-07-01
First Post: 2016-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module